Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
MacNicol AM
,
Hardy LL
,
Spencer HJ
,
MacNicol MC
.
???displayArticle.abstract???
BACKGROUND: There is increasing evidence of a pivotal role for regulated mRNA translation in control of developmental cell fate transitions. Physiological and pathological stem and progenitor cell self-renewal is maintained by the mRNA-binding protein, Musashi1 through repression of translation of key mRNAs encoding cell cycle inhibitory proteins. The mechanism by which Musashi1 function is modified to allow translation of these target mRNAs under conditions that require inhibition of cell cycle progression, is unknown.
RESULTS: In this study, we demonstrate that differentiation of primary embryonic rat neural stem/progenitor cells (NSPCs) or human neuroblastoma SH-SY5Y cells results in the rapid phosphorylation of Musashi1 on the evolutionarily conserved site serine 337 (S337). Phosphorylation of this site has been shown to be required for cell cycle control during the maturation of Xenopus oocytes. S337 phosphorylation in mammalian NSPCs and human SH-SY5Y cells correlates with the de-repression and translation of a Musashi reporter mRNA and with accumulation of protein from the endogenous Musashi target mRNA, p21(WAF1/CIP1). Inhibition of Musashi regulatory phosphorylation, through expression of a phospho-inhibitory mutant Musashi1 S337A or over-expression of the wild-type Musashi, blocked differentiation of both NSPCs and SH-SY5Y cells. Musashi1 was similarly phosphorylated in NSPCs and SH-SY5Y cells under conditions of nutrient deprivation-induced cell cycle arrest. Expression of the Musashi1 S337A mutant protein attenuated nutrient deprivation-induced NSPC and SH-SY5Y cell death.
CONCLUSIONS: Our data suggest that in response to environmental cues that oppose cell cycle progression, regulation of Musashi function is required to promote target mRNA translation and cell fate transition. Forced modulation of Musashi1 function may present a novel therapeutic strategy to oppose pathological stem cell self-renewal.
???displayArticle.pubmedLink???
25888190
???displayArticle.pmcLink???PMC4369890 ???displayArticle.link???BMC Dev Biol ???displayArticle.grants???[+]
Figure 1.
Musashi undergoes regulatory phosphorylation in response to neural differentiation. (A) Primary embryonic rat neural stem/progenitor cells (NSPCs) were maintained as neurospheres in proliferation media (prolif) or plated on adherent substrate in differentiation media for 2 hrs (diff). Protein lysates were processed for western blotting with the indicated antibodies. (B) Human neuroblastoma SH-SY5Y cells were maintained as neurospheres in proliferation media (prolif), or under differentiation conditions (diff) for the indicated times and analyzed by western blotting with the indicated antibodies.
Figure 2.
De-repression of a Musashi-dependent reporter mRNA during differentiation of SH-SY5Y cells. (A) SH-SY5Y cells were transfected with plasmids encoding luciferase reporter mRNAs under control of a Musashi binding element (MBE) or a control 3′ UTR (Control) and luciferase activity was assessed, relative to a co-transfected Renilla luciferase standard, following culture under proliferation or differentiation conditions for 24 hours. The dot plot shows the relative luciferase activity of six independent experiments as a percent of the 3′ UTR control (100%) for both proliferation and differentiation, as indicated. Luciferase expression was repressed in proliferating cells (mean of 77% with a 95% confidence interval: 73 to 81%; p < 0.0001, one sample t-test) but not in differentiated cells (mean of 97.7% with a 85% confidence interval 90.6 to 105.4%, p > 0.47, one sample t-test). (B) Western blot demonstrating persistence of Musashi1 in SH-SY5Y cells 24 hours after induction of differentiation. In this experiment, 10, 20 and 30 μg total protein (as indicted) were analyzed for Musashi1 and GAPDH protein levels from proliferating neurosphere culture (Prolif) or cells cultured in neuronal differentiation media for 24 hours (Diff). A representative experiment is shown.
Figure 3.
Overexpression of Musashi1 blocks neural differentiation. NSPCs (panels A-D) and SH-SY5Y cells (panels E-H) were transfected with a plasmid encoding the eGFP moity alone (A and E), wild-type Musashi1 (B and F) or Musashi1 encoding a non-phosphorylatable S337A mutation (C and F) fused to a C-terminal eGFP epitope tag and incubated at low cell density under differentiation conditions for 4 days (NSPCs) or 7 days (SH-SY5Y) and scored for initiation of differentiation phenotype (hypertrophic cells with neurites > 2 soma lengths). Representative photos shown. Some variations in the intensity and subcellular distribution of Musashi1 or Musashi1 S337A were noted in transfected cells within the same experiment. Over the course of three experiments, a total of 70 NSPC cells (A) or 136 SHSY5Y cells (E) transfected with eGFP alone were counted. (D and H) represent histograms showing quantitation of the differentiation data (mean of three experiments with SEM) at 14 days (D) or 7 days (H). ****,p < 0.0001 for (D); **,p < 0.01 for (H)) as assessed by one-way ANOVA.
Figure 4.
Inhibition of Musashi phosphorylation promotes cell survival. (A) NSPCs and (B) SH-SY5Y cells were transfected with the eGFP tagged Musashi proteins described in Figure 3 and fluorescent cells were photographed and counted 1 day after transfection then maintained under conditions of serum deprivation for 14 days (NSPC) or 4 days (SH-SY5Y) and counted relative to cell expressing the control, eGFP tag alone. Histogram represents the mean of the three experiments with SEM. The difference in surviving cell numbers were significant (**,p < 0.01 for NSPCs; ****,p < 0.0001 for SH-SY5Y cells). (C) SH-SY5Y cells were maintained as neurospheres in control proliferation media (Con) or plated on adherent substrate under conditions of serum starvation for 3 days (SS). Protein lysates were processed for western blotting with the indicated antibodies.
Arumugam,
Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.
2010, Pubmed,
Xenbase
Arumugam,
Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.
2010,
Pubmed
,
Xenbase
Arumugam,
Ringo/cyclin-dependent kinase and mitogen-activated protein kinase signaling pathways regulate the activity of the cell fate determinant Musashi to promote cell cycle re-entry in Xenopus oocytes.
2012,
Pubmed
,
Xenbase
Battelli,
The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1.
2006,
Pubmed
Biedermann,
The Quaking family of RNA-binding proteins: coordinators of the cell cycle and differentiation.
2010,
Pubmed
Bish,
RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma.
2014,
Pubmed
Bitterman,
Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
2012,
Pubmed
Cahan,
Origins and implications of pluripotent stem cell variability and heterogeneity.
2013,
Pubmed
Cao,
Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord.
2002,
Pubmed
Charlesworth,
The temporal control of Wee1 mRNA translation during Xenopus oocyte maturation is regulated by cytoplasmic polyadenylation elements within the 3'-untranslated region.
2000,
Pubmed
,
Xenbase
Charlesworth,
A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.
2002,
Pubmed
,
Xenbase
Charlesworth,
Musashi regulates the temporal order of mRNA translation during Xenopus oocyte maturation.
2006,
Pubmed
,
Xenbase
Charlesworth,
Cytoplasmic polyadenylation element (CPE)- and CPE-binding protein (CPEB)-independent mechanisms regulate early class maternal mRNA translational activation in Xenopus oocytes.
2004,
Pubmed
,
Xenbase
Cragle,
Musashi protein-directed translational activation of target mRNAs is mediated by the poly(A) polymerase, germ line development defective-2.
2014,
Pubmed
,
Xenbase
Davis,
Biological methods for cell-cycle synchronization of mammalian cells.
2001,
Pubmed
Erhardt,
Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment.
1998,
Pubmed
Heinrich,
MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment.
2012,
Pubmed
Hemmati,
Cancerous stem cells can arise from pediatric brain tumors.
2003,
Pubmed
Horisawa,
3'-Untranslated region of doublecortin mRNA is a binding target of the Musashi1 RNA-binding protein.
2009,
Pubmed
Hughes,
Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53. Simultaneous differentiation and proliferation subsequent to p53 functional inactivation.
2000,
Pubmed
Imai,
The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA.
2001,
Pubmed
Ito,
Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
2010,
Pubmed
Kanemura,
Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.
2001,
Pubmed
Kawahara,
Musashi1 cooperates in abnormal cell lineage protein 28 (Lin28)-mediated let-7 family microRNA biogenesis in early neural differentiation.
2011,
Pubmed
Kharas,
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
2010,
Pubmed
MacNicol,
Function and regulation of the mammalian Musashi mRNA translational regulator.
2008,
Pubmed
,
Xenbase
MacNicol,
Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation.
2011,
Pubmed
,
Xenbase
MacNicol,
Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF.
1993,
Pubmed
,
Xenbase
Muto,
RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
2012,
Pubmed
Nakamura,
The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells.
2000,
Pubmed
Okano,
Function of RNA-binding protein Musashi-1 in stem cells.
2005,
Pubmed
Orkin,
The transcriptional network controlling pluripotency in ES cells.
2008,
Pubmed
Oskarsson,
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.
2011,
Pubmed
Park,
Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs.
2014,
Pubmed
Rutledge,
Efficient translation of Dnmt1 requires cytoplasmic polyadenylation and Musashi binding elements.
2014,
Pubmed
,
Xenbase
Sakakibara,
RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation.
2002,
Pubmed
Sarkar,
The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.
2013,
Pubmed
Schiapparelli,
Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.
2010,
Pubmed
Shi,
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
2012,
Pubmed
Spears,
Novel double-negative feedback loop between adenomatous polyposis coli and Musashi1 in colon epithelia.
2011,
Pubmed
Sureban,
Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.
2008,
Pubmed
Toda,
Expression of the neural RNA-binding protein Musashi1 in human gliomas.
2001,
Pubmed
Torres-Padilla,
Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage.
2014,
Pubmed
Vo,
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
2012,
Pubmed
Wang,
Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.
2010,
Pubmed
Wang,
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.
2013,
Pubmed
Warfel,
p21WAF1 and tumourigenesis: 20 years after.
2013,
Pubmed
Yan,
NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.
1995,
Pubmed
Yokota,
Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization.
2004,
Pubmed
Young,
Control of the embryonic stem cell state.
2011,
Pubmed
de Andrés-Aguayo,
Musashi 2 in hematopoiesis.
2012,
Pubmed
de Sousa Abreu,
Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.
2009,
Pubmed
